It is estimated that only one-third of the people with bipolar disorder are correctly diagnosed, and even fewer are receiving appropriate treatment. This information is of concern, particularly in light of emerging data reflecting the potential negative consequences of failed or delayed diagnosis and lack of focused treatment. The article attempts to illuminate this complex disorder by describing the bipolar spectrum through a review of the criteria for diagnosis, aswell as practical advice on improving the detection of the disorder. Treatment options for bipolar disorder, with a focus on the latest pharmacological evidence base, as well as clinical recommendations regarding the safe and effective use of mood stabilizers and antidepressants are presented.
Akiskal, H. S. (1996). The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. Journal of Clinical Psychopharmacology, 16(Suppl. 1), 4S-14S.
2.
Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Keller, M., et al. (1995). Switching from ‘unipolar’ to bipolar II. An11-year prospective study of clinical and temperamental predictors in 559 patients. Archives of General Psychiatry, 52, 114-123.
3.
Akiskal, H. S., & Pinto, O. (1999). The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatric Clinics of North America, 22, 517-534.
4.
Altman, E. G., Hedeker, D., Peterson, J. L., & Davis, J. M. (1997). The Altman Self-Rating Mania Scale. Biological Psychiatry, 42, 948-955.
5.
Altman, E. G., Hedeker, D. R., Janicak, P., Peterson, J. L., & Davis, J. M. (1994). The Clinician-Administered Rating Scale for Mania (CARS-M): Development, reliability, and validity. Biological Psychiatry, 36, 124-134.
6.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders(4th ed.). Washington, DC: Author.
7.
American Psychiatric Association. (1995). Diagnostic and statistical manual of mental disorders—Primary care. Washington, DC: Author.
8.
American Psychiatric Association. (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159(Suppl. 4), 1-50.
9.
Bauer, M. S., Crits-Christoph, P., Ball, W. A., Dewees, E., McAllister, T., Alahi P., et al. (1991). Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Archives of General Psychiatry, 48, 807-812.
10.
Berk, M., Ichim, L., & Brook, S. (1999). Olanzapine compared to lithium in mania: A double-blind randomized controlled trial. International Clinical Psychopharmacology, 14, 339-343.
11.
Bowden, C. L., Calabrese, J. R., McElroy, S. L., Gyulai, L., Wassef, A., Petty, F., et al. (2000). A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Archives of General Psychiatry, 57, 481-489.
12.
Bowden, C. L., Calabrese, J. R., Sachs, G., Yatham, L. N., Asghar, S. A., Hompland, M., et al. (2003). Aplacebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry, 60, 392-400.
13.
Calabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O. P., et al. (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry, 64, 1013-1024.
14.
Calabrese, J. R., Shelton, M. D., Bowden, C. L., Rapport, D. J., Suppes, T., Shirley, E. R., et al. (2001). Bipolar rapid cycling: Focus on depression as its hallmark. Journal of Clinical Psychiatry, 62(Suppl. 14), 34-41.
15.
Centers for Disease Control and Prevention. (1999). Suicide in the United States. Retrieved February 9, 2004, from http://www.cdc.gov/ncipc/factsheets/suifacts.htm
16.
Data on file, AstraZeneca, Trial 99.
17.
Dennehy, E. B., & Suppes, T. (1999). Medication algorithms for bipolar disorder. Journal of Practical Psychiatry and Behavioral Health, 5, 142-152.
18.
Drug Facts and Comparisons. (2003). St. Louis, MO: Wolters Kluwer Health Inc.
19.
Endicott, J., & Spitzer, R. L. (1978). A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry, 35, 837-844.
20.
Ghaemi, S. N., Sachs, G. S., Chiou, A. M., Pandurangi, A. K., & Goodwin, K. (1999). Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?Journal of Affective Disorders, 52, 135-144.
21.
Glaxo Smith Kline.(2004, January). Lamotrigine. Retrieved December 12, 2003, from http://us.gsk.com/products/assets/us_lamictal.pdf
22.
Hamilton, M.(1960). Arating scale for depression. Journal of Neurology, Neurosurgery, & Psychiatry, 23, 56-62.
23.
Henry, C., Van den, B. D., Bellivier, F., Etain, B., Rouillon, F., & Leboyer, M. (2003). Anxiety disorders in 318 bipolar patients: Prevalence and impact on illness severity and response to mood stabilizer. Journal of Clinical Psychiatry, 64, 331-335.
24.
Hirschfeld, R. M., Calabrese, J. R., Weissman, M. M., Reed, M., Davies, M. A., Frye, M. A., et al. (2003). Screening for bipolar disorder in the community. Journal of Clinical Psychiatry, 64, 53-59.
25.
Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Jr., et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157, 1873-1875.
26.
Jamison, K. R. (2000). Suicide and bipolar disorder. Journal of Clinical Psychiatry, 61(Suppl. 9), 47-51.
27.
Keck, P. E., Jr., & Way, A. S. (2002, May). Practical approaches to recognizing and managing side effects. annual meeting of the American Psychiatric Association, Philadelphia, PA.
28.
Kennedy, D., & Koren, G. (1998). Valproic acid use in psychiatry: Issues in treating women of reproductive age. Journal of Psychiatry & Neuroscience, 23, 223-228.
29.
Maj, M. (1990). Clinical prediction of response to lithium prophylaxis in bipolar patients: The importance of the previous pattern of course of the illness. Clinical Neuropharmacology, 13(Suppl. 1), S66-S70.
30.
Medical Economics. (2003). Physicians’ desk reference(57th ed.). Montvale, NJ: Author.
31.
National Institute of Mental Health. (1976). Clinical Global Impression (CGI). In W. Guy (Ed.), ECDEU assessment manual for psychopharmacology(Publication ADM 76-338, pp. 217–222). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch.
32.
Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
33.
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., & Judd, L. L. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
34.
Rihmer, Z., Szadoczky, E., Furedi, J., Kiss, K., & Papp, Z. (2001). Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: Results from a population-based study in Hungary. Journal of Affective Disorders, 67, 175-179.
35.
Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002). Combination of a mood stabilizer with risperidone or haloperidol for treatment of acutemania: Adouble-blind, placebocontrolled comparison of efficacy and safety. American Journal of Psychiatry, 159, 1146-1154.
36.
Suppes, T., & Dennehy, E. B. (2002, August). TIMAprocedure manual: Bipolar disorder algorithms. Retrieved February 28, 2004, from http://www.mhmr.state.tx.us/centraloffice/medicaldirector/TIMABDman.pdf
37.
Tamam, L., & Ozpoyraz, N. (2002). Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology, 35, 203-209.
38.
Tohen, M., Baker, R. W., Altshuler, L. L., Zarate, C. A., Suppes, T., Ketter, T. A., et al. (2002). Olanzapine versus divalproex in the treatment of acute mania. American Journal of Psychiatry, 159, 1011-1017.
39.
Tohen, M., Chengappa, K. N., Suppes, T., Zarate, C. A., Jr., Calabrese, J. R., Bowden, C. L., et al. (2002). Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry, 59, 62-69.
40.
Tohen, M., Chengappa, K. N. R., Suppes, T., Baker, R. W., ZarateC. A., Jr., Bowden, C. L., et al. (2002, May). Olanzapine combined with lithium or valproate for relapse prevention of bipolar disorder: An 18-month study. annual meeting of the American Psychiatric Association, Philadelphia, PA.
41.
Tohen, M., Jacobs, T. G., Grundy, S. L., McElroy, S. L., Banov, M. C., Janicak, P. G., et al. (2000). Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Archives of General Psychiatry, 57, 841-849.
42.
Tohen, M., Sanger, T. M., McElroy, S. L., McElroy, S. L., Tollefson, G. D., Chengappa, K. N., et al. (1999). Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. American Journal of Psychiatry, 156, 702-709.
43.
Tondo, L., Baldessarini, R. J., Hennen, J., Floris, G., Silvetti, F., & Tohen, M. F. (1998). Lithium treatment and risk of suicidal behavior in bipolar disorder patients. Journal of Clinical Psychiatry, 59, 405-414.
44.
Yerevanian, B. I., Koek, R. J., & Ramdev, S. (2001). Anxiety disorders comorbidity in mood disorder subgroups: Data from a mood disorders clinic. Journal of Affective Disorders, 67, 167-173.
45.
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity, and sensitivity. British Journal of Psychiatry, 133, 429–435.
46.
Zajecka, J. M., Weisler, R., Sachs, G., Swann, A. C., Wozniak, P., & Sommerville, K. W. (2002). Acomparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. Journal of Clinical Psychiatry, 63, 1148-1155.
47.
Zornberg, G. L., & Pope, H. G. (1993). Treatment of depression in bipolar disorder: new directions for research. Journal of Clinical Psychopharmacology, 13, 397-408.
